ASX Cannabis Players, page-18

AGH holding on well considering hostile market, great quarterly result for Althea.

Cronos Australia holding steady, with a solid wall at .28c, quarterly results due any day now, smart to bring it out on the turn of the market, and make it a GREEN day.


ASX Announcement I 26 April 2022
Althea Group Holdings (ASX:AGH)

Quarterly Results and Highlights for the period ending 31 March 2022
AGH achieves record quarter with $5.5 million in receipts from customers, an
increase of 100% on the previous corresponding period
Financial Highlights:
Group
• AGH has achieved another record quarter with $5.5 million in receipts from customers for the
period ending 31 March 2022 – an increase of 100% from the previous corresponding period
• The result was achieved despite the seasonal effect experienced in January, a time of year
in which many primary care doctors take extended leave, exacerbated in 2022 by the easing
of prolonged COVID-19 restrictions along with the floods in Queensland and Northern NSW
• AGH anticipates a material increase in receipts from customers during the current quarter
• The Company remains fully funded with approximately $8 million of cash on hand
Division
• Recreational cannabis - AGH’s wholly owned subsidiary, Peak Processing Solutions (‘Peak’),
achieved a record $2.8 million in receipts from customers for the Reporting Period
• Pharmaceutical cannabis - AGH’s global cannabis-based medicines business, Althea,
achieved $2.7 million in receipts from customers for the Quarter
26 April 2022: Althea Group Holdings Limited (ASX:AGH) (‘AGH’, or ‘the Company’), a global leader
in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis
products, is pleased to present its Appendix 4C cash flow statement and operational update for the
quarter ended 31 March 2022 (‘Quarter’, ‘Reporting Period’).
Financial update for the Quarter
AGH has achieved another record quarter with $5.5 million in receipts from customers for the period
ending 31 March 2022, an increase of 100% from the previous corresponding period.
This result is despite the seasonal effect experienced in January, a time of year in which many primary
care doctors take extended leave, exacerbated in 2022 by the easing of prolonged COVID-19
restrictions along with the floods in Queensland and Northern NSW.
Further highlights during the Quarter include:
• An increase of $2.8 million, or 100%, in receipts from customers from the previous
corresponding period
• Peak achieved $2.8 million in receipts from customers for the Reporting Period - an increase
of 6% from the prior quarter